SEC Form 4 · accession 0001127602-18-021984
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Causey
Director
Period of report
Jun 26, 2018
Accepted (ET)
Jun 28, 2018 · 6:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 28, 2018 | M | 1,620 | $0.00 | A | 3,175 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2,F3 | $112.14 | Jun 26, 2018 | A | 9,240 | A | Jun 26, 2019 | Jun 26, 2028 | Common Stock | 9,240 | 9,240 | D |
| Restricted Stock UnitsF4,F5 | $0.00 | Jun 28, 2018 | M | 1,620 | D | — | — | Common Stock | 1,620 | 0 | D |
Explanation of responses
- F1Shares received upon vesting of restricted stock units on June 28, 2018. Restricted stock units converted on a one-for-one basis into shares of common stock.
- F2Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders.
- F3Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
- F4Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F5Restricted stock units were granted on June 28, 2017, and vested on June 28, 2018. The entire number of restricted stock units converted into shares of common stock upon vesting.